Atlas Trials

Evaluation of the Effect of Genetic Polymorphisms in ERCC1 and OCT2 on the Occurrence and Severity of Cisplatin-induced Nephrotoxicity

Clinical trial NCT05247671 · UNKNOWN

Trial details

NCT number
NCT05247671
Sponsor
Ain Shams University
Status
UNKNOWN
Study type
OBSERVATIONAL
Cisplatin Adverse Reaction
Start date
2022-02-15
Primary completion
2022-08-15
Enrollment
89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.